Two continents. One simple choice.

Although an ocean may divide them, when it comes to choosing the right pharma services company, distance knows no bounds.

As market leaders in an abecedarian of pharmaceutical services, European-based QUINTA-ANALYTICA are proud to have been chosen to provide a plethora of their offerings by US transdermal patch technology specialists, Greene Street Pharmaceuticals, despite being located a ‘mere’ 7000km away.

Being selected over more local service providers, Quinta-Analytica has been contracted as the exclusive API sourcing partner and CRO for BE studies, bioanalytical analyses, and preclinical studies for Greene Street as it strengthens its foothold in bringing transdermal solutions to the mainstream.

By selecting Quinta-Analytica with its world-class network of services, over 20 years of experience and fully certified coverage of the whole pharmaceutical spectrum, it will enable Greene Street to realize its model of offering a combination of discovery, development, and direct manufacture of transdermals both at home and abroad.

Are looking for a world-class pharmaceuticalindustry service provider? Don’t let geography influence you, get in touch with us today!

Additional News

  • 3 September 2026

    Quinta-Analytica Expands HPLC Fleet to Strengthen Flexibility and Capacity for Clients

    New Thermo Scientific Vanquish Core joins an HPLC fleet of around 50 systems

  • 7 August 2026

    Quinta-Analytica at CPHI Milan 2026 – Meet Us at Conscio Group Stand 6N25

    Meet Quinta-Analytica at CPHI Milan 2026 as part of the Conscio Group team at Stand 6N25. Discuss your clinical, bioanalytical and analytical projects with our experts and arrange a meeting in advance.

  • 15 July 2026

    Quinta-Analytica Awarded the EcoVadis Gold Medal

    Quinta-Analytica has been awarded the EcoVadis Gold Medal after achieving an overall sustainability score of 84 out of 100. The result represents a substantial increase from 68 points in the previous assessment and places the company in the 97th percentile globally.